Literature DB >> 11344033

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis.

H D. Foda1, S Zucker.   

Abstract

Matrix metalloproteinases (MMPs) are a family of proteinases that play an important role in cancer as well as in numerous other diseases. In this article, we summarize the current views on the role of MMPs in cancer with respect to invasion, metastasis and angiogenesis. A positive correlation between tumor progression and the expression of multiple MMP family members in tumor tissues has been demonstrated in numerous human and animal studies. It has been assumed that cancer cells are responsible for producing the MMPs in human tumors. However, recent evidence suggests that tumor cells have docking sites that bind stromal-cell-secreted MMPs. Furthermore, the role of MMPs produced by endothelial cells, especially MMP-2 and MT1-MMP, appear to be crucial for tumor angiogenesis, which is a requirement for cancer growth and dissemination.

Entities:  

Year:  2001        PMID: 11344033     DOI: 10.1016/s1359-6446(01)01752-4

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  78 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

2.  Molecular Imaging of Proteases in Cancer.

Authors:  Yunan Yang; Hao Hong; Yin Zhang; Weibo Cai
Journal:  Cancer Growth Metastasis       Date:  2009-08-17

3.  Effects of molecular weight and loading on matrix metalloproteinase-2 mediated release from poly(ethylene glycol) diacrylate hydrogels.

Authors:  Amy E Ross; Mary Y Tang; Richard A Gemeinhart
Journal:  AAPS J       Date:  2012-04-26       Impact factor: 4.009

4.  Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.

Authors:  Elisabeth L Bair; Man Ling Chen; Kathy McDaniel; Kiyotoshi Sekiguchi; Anne E Cress; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 5.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

6.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

7.  Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.

Authors:  Xiaolan Feng; Pan Wang; Quanhong Liu; Ting Zhang; Bingjie Mai; Xiaobing Wang
Journal:  J Bioenerg Biomembr       Date:  2015-01-29       Impact factor: 2.945

Review 8.  Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.

Authors:  Lei Chen; Hong-Yu Zhang
Journal:  Molecules       Date:  2007-05-03       Impact factor: 4.411

9.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

10.  Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis.

Authors:  Athina-Myrto Chioni; Richard Grose
Journal:  Fibrogenesis Tissue Repair       Date:  2008-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.